阿齐思罗米大规模药物管理和儿童生存的溢出:一个集群随机临床试验的二次分析
Ahmed M Arzika1, Abdou Amza2, Ramatou Maliki1
1Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger.
JAMA network open
|July 10, 2025
概括
针对儿童存活率的大规模阿齐思罗米辛的使用可能会降低婴儿死亡率,特别是当家庭中年长的孩子也接受治疗时. 这一发现支持针对儿童健康的更广泛的公共卫生战略.
科学领域:
- 全球健康 全球健康
- 传染性疾病 传染性疾病
- 儿科 儿科 儿科
背景情况:
- 世界卫生组织的指导方针建议为婴儿 (1-11个月) 给予大规模的阿齐思罗迈,以改善儿童的生存率.
- 之前的研究包括了更广泛的年龄范围 (1-59个月),而AVENIR试验表明,当同一家庭的老年儿童 (12-59个月) 被纳入时,可能会有好处.
研究的目的:
- 为了调查阿齐思罗米大规模药物管理的潜在溢出效应.
- 根据家庭中年龄较大的儿童 (12-59个月) 的存在,检查阿兹罗密辛治疗与婴儿 (1-11个月) 死亡率之间的关联.
主要方法:
- 尼日尔AVENIR适应性集群随机临床试验的二次分析.
- 婴儿 (1-11个月) 的全因死亡率在三个手臂中进行了比较:儿童 (1-59个月) 的阿齐思罗米,婴儿 (1-11个月) 的阿齐思罗米,较大的儿童的安慰剂,以及所有儿童的安慰剂.
- 根据家庭中12-59个月的儿童的存在进行子组分析.
主要成果:
- 每1000人年死亡率在儿童组为18.5,婴儿组为22.3,安慰剂组为23.9.
- 在有大兄弟姐妹的婴儿中,比较儿童手臂与婴儿手臂的死亡率发生率比率为0.78 (95% CI,0.65-0.93).
- 对于老兄弟姐妹的存在,没有发现统计学意义上的相互作用,但趋势表明,与接受治疗的老年儿童一起生活的婴儿的死亡率较低.
结论:
- 虽然在统计学上并不显著,但结果表明,当同一个家庭的老年儿童 (12-59个月) 接受大规模阿兹罗米辛治疗时,可能会对婴儿 (1-11个月) 的死亡率有好处.
- 这些发现支持在儿童存活计划中探索更广泛的针对年龄群体的阿齐思罗米辛药物管理策略.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.9K
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.6K
相关概念视频
01:21Factors Affecting Drug Response: Overview
2.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.3K
01:28Antimicrobial Effectiveness
156
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156
01:19Pharmacovigilance
981
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
981
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173
01:16Clinical Trials
7.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.5K
01:11Testing a Claim about Mean: Known Population SD
2.8K
A complete procedure of testing the hypothesis about a population mean is explained here.
Estimating a population mean requires the samples to be distributed normally. The data should be collected from the randomly selected samples having no sampling bias. The sample size needed to be higher than 30, and most importantly, the population standard deviation should be already known.
In most realistic situations, the population standard deviation is often unknown, but in rare circumstances, when it...
Estimating a population mean requires the samples to be distributed normally. The data should be collected from the randomly selected samples having no sampling bias. The sample size needed to be higher than 30, and most importantly, the population standard deviation should be already known.
In most realistic situations, the population standard deviation is often unknown, but in rare circumstances, when it...
2.8K